US6120789A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Non-polymeric sustained release delivery system
Assignee: Tolmar Therapeutics Inc
•
Filing: 1999-03-30
•
Granted: 2000-09-19
•
Expires: 2019-03-30
Abstract
Abstract The invention relates to a method and composition for forming an implant in-situ within a body using non-polymeric materials, and the use of such implants as medical devices and drug delivery systems. The composition can be applied to an animal to treat periodontal disease or other tissue defect, enhance compatibility and performance of an implantable article, and deliver a biologically active agent.
Inventors
- 👤 Richard L. Dunn
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 10:44
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0024; A61K47/00; A61K47/30; A61K47/34; A61P; A61P1/00; A61P1/02; A61K47/06; A61K47/08; A61K47/14; A61K47/20; A61K47/22; Y; Y02; Y02A; Y02A50/00; Y02A50/30
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
77 words
A flowable composition for forming a solid biodegradable implant in situ within a body, comprising: (a) a non-polymeric, water-insoluble material that is biodegradable, (b) a minor amount of biodegradable, bioabsorbable thermoplastic polymer; and (c) a biocompatible, organic solvent that is miscible to dispersible in water or body fluids, and capable of dissipating, diffusing or leaching from the composition into body fluid upon placement within a body, whereupon the non-polymeric material coagulates or precipitates to form the implant.
Claim 2
Dependent Claim
77 words
A flowable composition for forming a solid biodegradable implant in situ within a body, comprising: (a) a non-polymeric, water-insoluble material that is biodegradable, (b) a minor amount of biodegradable, bioabsorbable thermoplastic polymer; and (c) a biocompatible, organic solvent that is miscible to dispersible in water or body fluids, and capable of dissipating, diffusing or leaching from the composition into body fluid upon placement within a body, whereupon the non-polymeric material coagulates or precipitates to form the implant.
Claim 3
Independent Claim
110 words
A method of treating a tissue defect in an animal, comprising: (a) administering a flowable composition to the tissue defect, the composition comprising: (i) a non-polymeric, water-insoluble material that is biodegradable; (ii) a minor amount of a biodegradable, bioabsorbable thermoplastic polymer; and (iii) a biocompatible, organic solvent that at least partially solubilizes the non-polymeric, water-insoluble material and is miscible to dispersible in water or body fluids and capable of dissipating, diffusing or leaching from the composition into body fluid upon placement within a body; and (b) allowing the composition to coagulate or precipitate in situ to form a solid implant; wherein the implant is effective to treat the tissue defect.
Claim 4
Independent Claim
110 words
A method of treating a tissue defect in an animal, comprising: (a) administering a flowable composition to the tissue defect, the composition comprising: (i) a non-polymeric, water-insoluble material that is biodegradable; (ii) a minor amount of a biodegradable, bioabsorbable thermoplastic polymer; and (iii) a biocompatible, organic solvent that at least partially solubilizes the non-polymeric, water-insoluble material and is miscible to dispersible in water or body fluids and capable of dissipating, diffusing or leaching from the composition into body fluid upon placement within a body; and (b) allowing the composition to coagulate or precipitate in situ to form a solid implant; wherein the implant is effective to treat the tissue defect.
Claim 5
Dependent Claim
22 words
The method of claim 2, wherein the thermoplastic polymer is selected from the group consisting of polylactide, polycaprolactone, polyglycolide, and copolymers thereof.
Claim 6
Dependent Claim
23 words
The method according to claim 2, wherein the tissue defect is a tissue regeneration site, bone defect, periodontal pocket, wound, or surgical incision.
Claim 7
Dependent Claim
15 words
The method according to claim 2, wherein the composition further comprises a biologically active agent.
Claim 8
Dependent Claim
22 words
The method according to claim 2, wherein the composition is administered by injection, brushing, painting, coating, spraying, squirting, or a combination thereof.
Claim 9
Dependent Claim
24 words
The method according to claim 6, wherein the composition is administered via a cannula, catheter, syringe, syringe with a needle, pressure applicator, or pump.
Claim 10
Dependent Claim
48 words
A method of delivering a biologically-active agent to an animal, comprising: (a) administering a composition according to claim 1 to the animal; and (b) allowing the composition to coagulate or precipitate in situ to form a solid implant; wherein the biologically active agent is delivered to the animal.
Claim 11
Dependent Claim
48 words
A method of treating periodontal disease, comprising: (a) administering to gingival tissue of a patient, a composition according to claim 1; and (b) allowing the composition to coagulate or precipitate in situ to form a solid implant; wherein the implant is effective to treat the periodontal diseased tissue.
Claim 12
Dependent Claim
66 words
A method for enhancing the compatibility, function or both, or a surgically implantable device with a body tissue, comprising applying the composition according to claim 1 to the surgically implantable device, to a body tissue, or a combination of both; wherein the combination of the composition with the device is effective to enhance the compatibility, function or both, of the implantable device with the body tissue.
Claim 13
Dependent Claim
23 words
The method according to claim 10, wherein the implantable device is a suture, clasp, prosthesis, catheter, metal screw, bone plate, pin, or bandage.
Claim 14
Dependent Claim
22 words
The composition of claim 1, wherein the thermoplastic polymer is selected from the group consisting of polylactide, polycaprolactone, polyglycolide, and copolymers thereof.
References Cited (Backward Citations)
US3887699A
Cited
US4093709A
Cited
US4138344A
Cited
US4148871A
Cited
US4292965A
Cited
US4341728A
Cited
US4675189A
Cited
US4452775A
Cited
US4906474A
Cited
US4702719A
Cited
WO1988007816A1
Cited
US5278202A
Cited
US5340849A
Cited
US4938763A
Cited
US4938763B1
Cited
WO1990003768A1
Cited
US5278201A
Cited
US4906476A
Cited
US5324520A
Cited
US5324519A
Cited
WO1991001126A1
Cited
US5368859A
Cited
US5077049A
Cited
WO1992000718A1
Cited
EP0537559A1
Cited
EP0539751A1
Cited
EP0560014A1
Cited
EP0649662A1
Cited
WO1995027481A1
Cited
US5736152A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-09-19 | 2004-03-20 | 2004-09-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-09-19 | 2008-03-20 | 2008-09-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-09-19 | 2012-03-20 | 2012-09-19 | $7700.00 | Window Closed / Lapsed |